ADVANCING VACCINES AND BIOTHERAPEUTICS

ABL has been ranked ‘Excellent’ for ELISPOT testing with EQAPOL external quality assurance program.

ABL scientists are working to conquer today’s most challenging diseases

ABL utilizes its strong core of product development expertise, GMP manufacturing and immunological testing capabilities toward advancing your candidate vaccines and therapeutics through preclinical and clinical development. ABL’s experts are producing and testing today’s leading oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

ABL Strasbourg France facility

ABL Europe

Biomanufacturing
Strasbourg, France
Lyon, France

Advanced BioScience Laboratories (ABL) Rockville facility

ABL, Inc.

Biomanufacturing & Immunology
Rockville, MD, USA

BIOMANUFACTURING

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

IMMUNOBIOLOGY

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

PRODUCT TYPES

Gene therapy
Gene Therapies
oncolytic
Oncolytic Vectors
Vaccines
immunotherapy
Immunotherapies

Click here to see our media

ABL IN THE NEWS

bioreactor - small

ABL Europe, University Clinic of Tuebingen and Prime Vector Technologies partner for a 2nd generation COVID-19 vaccine

ABL supports fill/finish of COVID-19

ABL, Inc. Supports Fill/Finish of SARS-CoV-2 (COVID-19) Vaccine Candidate

Just-Evotec Biologics partners with ABL

Just - Evotec Biologics Partners With ABL On Development of Broadly Neutralising Antibody Against HIV

Themis collaborates with ABL to manufacture its COVID-19 vaccine

Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France